相关实验视频
Updated: Jul 10, 2025

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
33.2K
经过实验状态后,梅弗洛的抗发作和神经保护作用 epilepticusus
Mingting Shao1, Hang Yu2, Vijayalakshmi Santhakumar3
1Department of Neurosurgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu, China; Guangdong-Hongkong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China.
Epilepsy research
|November 21, 2023
概括
梅,一个差距连接阻塞剂,减少了鼠模型中的和行为问题. 它保护神经元免受损失,并保持抑制功能,这表明潜在的抗产生的效果.
科学领域:
- 神经科学是一个神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 获得的叶 (TLE) 涉及反复发作和海马抑制神经元功能障碍,往往耐治疗.
- 神经元间隙连接,特别是Connexin 36,与同步和神经退行有关.
- 阻止这些结点以预防慢性发作的可能性仍然未被探索.
研究的目的:
- 调查是否有选择性的Connexin 36阻断剂的梅花素可以在获得TLE的老鼠模型中限制发育和相关的病理.
- 评估梅花对自发性复发性发作 (SRS),神经元损失和后状态 (SE) 后行为并发症的影响.
主要方法:
- 在小鼠的皮洛卡尔诱导的SE后,在早期给予单剂量梅.
- 评估SRS发育和行为并发症.
- 使用免疫染色来评估内部神经元亚型和细胞损失.
- 进行全细胞补丁记录以测量抑制性突触驱动.
主要成果:
- 梅花治疗显著降低了SRS和行为相关疾病的发展.
- 这种药物似乎可以减轻SE后抑制神经元的延迟损失.
- 牙状环中的表达帕尔瓦胺神经元对早期细胞死亡表现出相对的抵抗力.
- 梅弗洛基因在SE后一周和一个月保存了抑制性突触驱动器到投射神经元.
结论:
- 在获得的TLE模型中,美弗洛基因显示出潜在的抗性质.
- 这种药物可以防止逐渐的内部神经元损失和相关的行为问题.
- 梅花在疟疾预防中的确立安全性概况,需要进一步研究治疗.
更多相关视频
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
Antiepileptic Drugs: Glutamate Antagonists
380
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
380
Arteries of the Lower Limbs
192
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
317
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
317
Antiepileptic Drugs: GABAergic Pathway Potentiators
419
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
419
Antiepileptic Drugs: Sodium Channel Blockers
597
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
597

